{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:45:00Z","timestamp":1788273900245,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSPD2024R709"],"award-info":[{"award-number":["RSPD2024R709"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-024-00785-z","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:33:13Z","timestamp":1724412793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A comprehensive insight from molecular docking and dynamics with clinical investigation on the impact of direct oral anticoagulants on atheroprotective protein in atrial fibrillation"],"prefix":"10.1186","volume":"25","author":[{"given":"M.","family":"Sudhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Janakiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramasamy","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durga","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiek S. S. J.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"785_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ijcard.2018.11.123","volume":"287","author":"CS Boerschel","year":"2019","unstructured":"Boerschel CS, Schnabel RB. The imminent epidemic of atrial fibrillation and its concomitant diseases\u2013myocardial infarction and heart failure-a cause for concern. Int J Cardiol. 2019;287:162\u201373. https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.123.","journal-title":"Int J Cardiol"},{"issue":"24","key":"785_CR2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3389\/fgene.2022.966413","volume":"105","author":"RS Wijesurendra","year":"2019","unstructured":"Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019;105(24):1860\u20137. https:\/\/doi.org\/10.3389\/fgene.2022.966413.","journal-title":"Heart"},{"issue":"1","key":"785_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4022\/jafib.467","volume":"5","author":"S Bordignon","year":"2012","unstructured":"Bordignon S, Chiara Corti M, Bilato C. Atrial fibrillation associated with heart failure, stroke, and mortality. J Atr Fibrillation. 2012;5(1):467. https:\/\/doi.org\/10.4022\/jafib.467.","journal-title":"J Atr Fibrillation"},{"issue":"4","key":"785_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cjca.2016.12.006","volume":"33","author":"HD Huang","year":"2017","unstructured":"Huang HD, Darbar D. Genetic risk scores for atrial fibrillation: do they improve risk estimation? Eur Heart J. 2017;33(4):422\u20134. https:\/\/doi.org\/10.1016\/j.cjca.2016.12.006.","journal-title":"Eur Heart J"},{"issue":"3","key":"785_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ejhf.1735","volume":"22","author":"M Kloosterman","year":"2020","unstructured":"Kloosterman M, Santema BT, Roselli C, Nelson CP, Koekemoer A, Romaine SP, Rienstra M. Genetic risk and atrial fibrillation in patients with heart failure. Eur J Heart Fail. 2020;22(3):519\u201327. https:\/\/doi.org\/10.1002\/ejhf.1735.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"785_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.chest.2018.03.040","volume":"154","author":"NA Bosch","year":"2018","unstructured":"Bosch NA, Cimini J, Walkey AJ. Atrial fibrillation in the ICU. Chest. 2018;154(6):1424\u201334. https:\/\/doi.org\/10.1016\/j.chest.2018.03.040.","journal-title":"Chest"},{"issue":"4","key":"785_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jcph.2184","volume":"63","author":"LV Bortman","year":"2023","unstructured":"Bortman LV, Mitchell F, Naveiro S, P\u00e9rez Morales J, Gonzalez CD, Di Girolamo G, Giorgi MA. Direct oral anticoagulants: an updated systematic review of their clinical pharmacology and clinical effectiveness and safety in patients with nonvalvular atrial fibrillation. J Clin Pharmacol. 2023;63(4):383\u201396. https:\/\/doi.org\/10.1002\/jcph.2184.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"785_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.33963\/KP.15205","volume":"78","author":"A Undas","year":"2020","unstructured":"Undas A, Drabik L, Potpara T. Bleeding in anticoagulated patients with atrial fibrillation: practical considerations. Kardiol Pol. 2020;78(2):105\u201316. https:\/\/doi.org\/10.33963\/KP.15205.","journal-title":"Kardiol Pol"},{"issue":"8","key":"785_CR9","doi-asserted-by":"publisher","first-page":"e008150","DOI":"10.1161\/JAHA.117.008150","volume":"7","author":"YH Chan","year":"2018","unstructured":"Chan YH, See LC, Tu HT, Yeh YH, Chang SH, Wu LS, et al. Efficacy and safety of apixaban, dabigatran, rivaroxaban, and warfarin in Asians with nonvalvular atrial fibrillation. J Am Heart Assoc. 2018;7(8):e008150. https:\/\/doi.org\/10.1161\/JAHA.117.008150.","journal-title":"J Am Heart Assoc"},{"key":"785_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/TCRM.S84210","volume":"11","author":"YH Mekaj","year":"2015","unstructured":"Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015;11:967\u201377. https:\/\/doi.org\/10.2147\/TCRM.S84210.","journal-title":"Ther Clin Risk Manag"},{"key":"785_CR11","doi-asserted-by":"publisher","first-page":"966413","DOI":"10.3389\/fgene.2022.966413","volume":"13","author":"M Vavlukis","year":"2022","unstructured":"Vavlukis M, Vavlukis A, Krsteva K, Topuzovska S. Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development. Front Genet. 2022;13:966413.","journal-title":"Front Genet"},{"key":"785_CR12","doi-asserted-by":"publisher","first-page":"108067","DOI":"10.1016\/j.diabres.2020.108067","volume":"161","author":"Y Shokri","year":"2020","unstructured":"Shokri Y, Variji A, Nosrati M, Khonakdar-Tarsi A, Kianmehr A, Kashi Z, et al. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: genotypic and phenotypic evaluation. Diabetes Res Clin Pract. 2020;161:108067. https:\/\/doi.org\/10.1016\/j.diabres.2020.108067.","journal-title":"Diabetes Res Clin Pract"},{"issue":"23","key":"785_CR13","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1177\/15353702221128563","volume":"248","author":"ZA Ghoreshi","year":"2023","unstructured":"Ghoreshi ZA, Abbasi-Jorjandi M, Asadikaram G, Sharif-Zak M, Seyedi F, Khaksari Haddad M, et al. Paraoxonase 1 rs662 polymorphism, its related variables, and COVID-19 intensity: considering gender and post-COVID complications. Exp Biol Med (Maywood). 2023;248(23):2351\u201362. https:\/\/doi.org\/10.1177\/15353702221128563.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"11","key":"785_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/1947-2714.103310","volume":"4","author":"D Litvinov","year":"2012","unstructured":"Litvinov D, Mahini H, Garelnabi M. Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases. N Am J Med Sci. 2012;4(11):523\u201332. https:\/\/doi.org\/10.4103\/1947-2714.103310.","journal-title":"N Am J Med Sci"},{"issue":"1","key":"785_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","volume":"567","author":"M Mackness","year":"2015","unstructured":"Mackness M, Mackness B. Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles. Gene. 2015;567(1):12\u201321. https:\/\/doi.org\/10.1016\/j.gene.2015.04.088.","journal-title":"Gene"},{"issue":"1","key":"785_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/cbdd.14054","volume":"100","author":"O Argan","year":"2022","unstructured":"Argan O, Cikrikci K, Uslu H, Gencer N. In vitro effects of thirty-eight cardiac drugs on human serum paraoxonase. Chem Biol Drug Des. 2022;100(1):80\u20139. https:\/\/doi.org\/10.1111\/cbdd.14054.","journal-title":"Chem Biol Drug Des"},{"issue":"3","key":"785_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/138920306777452312","volume":"7","author":"Z Xiang","year":"2006","unstructured":"Xiang Z. Advances in homology protein structure modeling. Curr Protein Pept Sci. 2006;7(3):217\u201327. https:\/\/doi.org\/10.2174\/138920306777452312.","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"785_CR18","doi-asserted-by":"publisher","first-page":"e1009781","DOI":"10.1371\/journal.pcbi.1009781","volume":"18","author":"AJ Bryer","year":"2022","unstructured":"Bryer AJ, Reddy T, Lyman E, Perilla JR. Full scale structural, mechanical, and dynamical properties of HIV-1 liposomes. PLoS Comput Biol. 2022;18(1):e1009781. https:\/\/doi.org\/10.1371\/journal.pcbi.1009781.","journal-title":"PLoS Comput Biol"},{"issue":"15","key":"785_CR19","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1021\/acs.jpcb.6b01316","volume":"120","author":"S Boonstra","year":"2016","unstructured":"Boonstra S, Onck PR, Giessen EV. CHARMM TIP3P water model suppresses peptide folding by solvating the unfolded state. J Phys Chem B. 2016;120(15):3692\u20138. https:\/\/doi.org\/10.1021\/acs.jpcb.6b01316.","journal-title":"J Phys Chem B"},{"key":"785_CR20","doi-asserted-by":"publisher","first-page":"1124563","DOI":"10.3389\/fmolb.2023.1124563","volume":"10","author":"C Kirubhanand","year":"2023","unstructured":"Kirubhanand C, Merciline Leonora J, Anitha S, Sangeetha R, Nachammai KT, Langeswaran K, et al. Targeting potential receptor molecules in non-small cell lung cancer (NSCLC) using in-silico approaches. Front Mol Biosci. 2023;10:1124563. https:\/\/doi.org\/10.3389\/fmolb.2023.1124563.","journal-title":"Front MolBiosci"},{"key":"785_CR21","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys. 1981;52:7182\u201390. https:\/\/doi.org\/10.1063\/1.328693.","journal-title":"J Appl Phys"},{"key":"785_CR22","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1021\/ct700200b","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJ, Fraaije JG. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18:1463\u201372. https:\/\/doi.org\/10.1021\/ct700200b.","journal-title":"J Comput Chem"},{"issue":"1","key":"785_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2008.11.001","volume":"235","author":"RJ Richter","year":"2009","unstructured":"Richter RJ, Jarvik GP, Furlong CE. Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol Appl Pharmacol. 2009;235(1):1\u20139. https:\/\/doi.org\/10.1016\/j.taap.2008.11.001.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"785_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.22092\/ARI.2022.357069.1965","volume":"77","author":"S Varadhan","year":"2022","unstructured":"Varadhan S, Venkatachalam R, Perumal SM, Ayyamkulamkara SS. Evaluation of oxidative stress parameters and antioxidant status in coronary artery disease patients. Arch Razi Inst. 2022;77(2):853\u20138. https:\/\/doi.org\/10.22092\/ARI.2022.357069.1965.","journal-title":"Arch Razi Inst"},{"issue":"1","key":"785_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.prnil.2017.04.002","volume":"6","author":"GA Asare","year":"2018","unstructured":"Asare GA, Andam SE, Asare-Anane H, Ammanquah S, Anang-Quartey Y, Afriyie DK, Musah I. Lipid-associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-na\u00efve patients. Prostate Int. 2018;6(1):36\u201340. https:\/\/doi.org\/10.1016\/j.prnil.2017.04.002.","journal-title":"Prostate Int"},{"issue":"7","key":"785_CR26","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.7860\/JCDR\/2013\/5144.3118","volume":"7","author":"M Shekhanawar","year":"2013","unstructured":"Shekhanawar M, Shekhanawar SM, Krisnaswamy D, Indumati V, Satishkumar D, Vijay V, et al. The role of \u2018paraoxonase-1 activity\u2019 as an antioxidant in coronary artery diseases. J Clin Diagn Res. 2013;7(7):1284. https:\/\/doi.org\/10.7860\/JCDR\/2013\/5144.3118.","journal-title":"J ClinDiagn Res"},{"issue":"4","key":"785_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/medicines6040103","volume":"6","author":"SA Kustos","year":"2019","unstructured":"Kustos SA, Fasinu PS. Direct-acting oral anticoagulants and their reversal Agents-An update. Medicines (Basel). 2019;6(4):103. https:\/\/doi.org\/10.3390\/medicines6040103.","journal-title":"Med (Basel)"},{"issue":"3","key":"785_CR28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/ijerph19031436","volume":"19","author":"S Rogula","year":"2022","unstructured":"Rogula S, G\u0105secka A, Mazurek T, Navarese EP, Szarpak \u0141, Filipiak KJ. Safety and efficacy of DOACs in patients with advanced and end-stage renal disease. Int J Environ Res Public Health. 2022;19(3):1436. https:\/\/doi.org\/10.3390\/ijerph19031436.","journal-title":"Int J Environ Res Public Health"},{"key":"785_CR29","doi-asserted-by":"publisher","unstructured":"Issever K, Kuloglu E, Muhtaroglu A, Seker D, Kotur O, Dulger AC. The effect of direct oral anticoagulants on gastric mucosa and Helicobacter Pylori prevalence in dyspeptic patients: a retrospective cross-sectional study. Cureus. 2023;15(10). https:\/\/doi.org\/10.7759\/cureus.46477.","DOI":"10.7759\/cureus.46477"},{"issue":"2","key":"785_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11096-022-01511-7","volume":"45","author":"A Capiau","year":"2023","unstructured":"Capiau A, Mehuys E, De Bolle L, Van Tongelen I, De Backer T, Boussery K. Drug-drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care. Int J Clin Pharm. 2023;45(2):364\u201374. https:\/\/doi.org\/10.1007\/s11096-022-01511-7.","journal-title":"Int J Clin Pharm"},{"key":"785_CR31","doi-asserted-by":"publisher","first-page":"1065967","DOI":"10.3389\/fcvm.2023.1065967","volume":"10","author":"PN Durrington","year":"2023","unstructured":"Durrington PN, Bashir B, Soran H. Paraoxonase 1 and atherosclerosis. Front Cardiovasc Med. 2023;10:1065967. https:\/\/doi.org\/10.3389\/fcvm.2023.1065967.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"785_CR32","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.3390\/ijms25052962","volume":"25","author":"TB Sirca","year":"2024","unstructured":"Sirca TB, Mure\u0219an ME, Pallag A, Marian E, Jurca T, Vica\u0219 LG, et al. The role of polyphenols in modulating PON1 activity regarding endothelial dysfunction and atherosclerosis. Int J Mol Sci. 2024;25(5):2962. https:\/\/doi.org\/10.3390\/ijms25052962.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"785_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2013.03.005","volume":"228","author":"S Aharoni","year":"2013","unstructured":"Aharoni S, Aviram M, Fuhrman B. Paraoxonase 1 (PON1) reduces macrophage inflammatory responses. Atherosclerosis. 2013;228(2):353\u201361. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.03.005.","journal-title":"Atherosclerosis"},{"issue":"6","key":"785_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4254\/wjh.v15.i6.841","volume":"15","author":"D Juneja","year":"2023","unstructured":"Juneja D, Nasa P, Jain R. Liver injury from direct oral anticoagulants. World J Hepatol. 2023;15(6):841\u20139. https:\/\/doi.org\/10.4254\/wjh.v15.i6.841.","journal-title":"World J Hepatol"},{"issue":"2","key":"785_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1039\/d3sc04629j","volume":"15","author":"WT Jauslin","year":"2023","unstructured":"Jauslin WT, Schild M, Schaefer T, Borsari C, Orbegozo C, Bissegger L, et al. A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3K\u03b1. Chem Sci. 2023;15(2):683\u201391. https:\/\/doi.org\/10.1039\/d3sc04629j.","journal-title":"Chem Sci"},{"key":"785_CR36","doi-asserted-by":"publisher","unstructured":"Pandi S, Kulanthaivel L, Subbaraj GK, Rajaram S, Subramanian S. Screening of potential breast cancer inhibitors through molecular docking and molecular dynamics simulation. Biomed Res Int. 2022;3338. https:\/\/doi.org\/10.1155\/2022\/3338549.","DOI":"10.1155\/2022\/3338549"},{"issue":"9","key":"785_CR37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/membranes12090844","volume":"12","author":"S Sinha","year":"2022","unstructured":"Sinha S, Tam B, Wang SM. Applications of molecular dynamics simulation in protein study. Membranes (Basel). 2022;12(9):844. https:\/\/doi.org\/10.3390\/membranes12090844.","journal-title":"Membr (Basel)"},{"issue":"12","key":"785_CR38","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.3390\/medicina59122060","volume":"59","author":"MSVJ Ahmad","year":"2023","unstructured":"Ahmad MSVJ, Attia SF, Emran SM, Patil TB, Ahmed RB. Structural characteristics of PON1 with Leu55Met and Gln192Arg variants influencing oxidative-stress-related diseases: an integrated molecular modeling and dynamics study. Medicina (Kaunas). 2023;59(12):2060. https:\/\/doi.org\/10.3390\/medicina59122060.","journal-title":"Med (Kaunas)"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-024-00785-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-024-00785-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:39:17Z","timestamp":1724413157000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-024-00785-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1186\/s40360-024-00785-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Human Institutional Ethical committee (IHEC-II\/0118\/21) of Chettinad Academy of Research and Education, Chettinad Hospital and Research Institute, Kelambakkam, Tamil Nadu\u2013 603103, India. We confirm that all methods were performed in accordance with the accordance with the Declaration of Helsinki. All participants gave written informed consent before recruitment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors on the research paper have approved the manuscript for submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}